Application 006530

Type
NDA
Sponsor
MYLAN SPECIALITY LP

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
003AVCSULFANILAMIDECREAM;VAGINAL15%YesYes
004AVCSULFANILAMIDESUPPOSITORY;VAGINAL1.05GMNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N006530-003AVCSULFANILAMIDE15% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CREAM / VAGINALRLD1987-01-27
N006530-004AVCSULFANILAMIDE1.05GMSUPPOSITORY / VAGINAL1987-01-27

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 3 of 3 · 90 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N006530-003AVC15% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CREAM / VAGINALRLD1987-01-273a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N006530-004AVC1.05GMSUPPOSITORY / VAGINAL1987-01-273a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N006530-003AVC15% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CREAM / VAGINALRLD1987-01-27f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10N006530-004AVC1.05GMSUPPOSITORY / VAGINAL1987-01-27f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N006530-003AVC15% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CREAM / VAGINALRLD1987-01-27e64feba35796…
2022-09-29 23:25 UTC2022-09N006530-004AVC1.05GMSUPPOSITORY / VAGINAL1987-01-27e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N006530-003AVC15%CREAM / VAGINALRLD1987-01-27cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N006530-004AVC1.05GMSUPPOSITORY / VAGINAL1987-01-27cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N006530-003AVC15% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CREAM / VAGINALRLD1987-01-27a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N006530-004AVC1.05GMSUPPOSITORY / VAGINAL1987-01-27a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 1 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0037-6631AVCsulfanilamideMeda PharmaceuticalsNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
32943SUPPL2013-01-23